Alamar Biosciences Raises $128M in to Accelerate Proteomics Platform
What You Should Know:
– Alamar Biosciences, a leader in precision proteomics for early disease detection raises $100M in Series C round, with an additional $28M expected within the next 30 days. This brings their…
Continue Reading